Group 1 - The company has clarified that its anti-hair loss foam product, KX-826, is part of its KOSHINÉ cosmetics brand and that the sales target of RMB 100 million is a long-term goal rather than a short-term sales expectation [1] - The cosmetics sales business is currently small and auxiliary compared to the company's core business of drug development and commercialization [1] - As of the announcement date, the company has 121 employees, with 69 dedicated to drug research and supply, and 24 focused on cosmetics sales and marketing [1] Group 2 - The board has confirmed that the cash flow from the cosmetics business will be used to fund medical and biological applications and development [2] - The company is actively negotiating bank financing expected to be granted in the first quarter of 2026 and is also seeking equity financing from potential investors [2] - The board believes that the company's financial resources and liquidity are sufficient to support its operations, research, and commercialization of core products [2]
开拓药业-B(09939)将利用化妆品业务的现金流量为医疗/生物应用及开发提供资金